BCM
PTLA

Beryl Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Beryl Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,560
Closed -$280K – 131
2020
Q2 		$280K Buy
+15,560
New +$216K 0.05% 49

Beryl Capital Management's PTLA Position: Q3 2020 in Review

Beryl Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 15,560 shares — an estimated $280K sold.

Beryl Capital Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $280K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Beryl Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Beryl Capital Management sold 15,560 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $280K.
  • Beryl Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Beryl Capital Management's Portola Pharmaceuticals, Inc. position peaked at $280K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Beryl Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.